Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients

BACKGROUND: Glioblastoma multiform (GBM) is a devastating brain tumor with maximum surgical resection, radiotherapy plus concomitant and adjuvant temozolomide (TMZ) as the standard treatment. Diverse clinicopathological and molecular features are major obstacles to accurate predict survival and eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wei-Zhen, Guo, Lie-Mei, Xu, Tian-Qi, Yin, Yu-Hua, Jia, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302404/
https://www.ncbi.nlm.nih.gov/pubmed/30572911
http://dx.doi.org/10.1186/s12967-018-1744-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302404/
https://www.ncbi.nlm.nih.gov/pubmed/30572911
http://dx.doi.org/10.1186/s12967-018-1744-8

Ejemplares similares